Funding for this research was provided by:
Microlife
Article History
Received: 24 June 2019
Accepted: 23 October 2019
First Online: 7 November 2019
Compliance with ethical standards
:
: Dr Lane has received investigator-initiated educational grants from Bristol Myers Squibb (BMS) and Boehringer Ingelheim; speaker for Boehringer Ingelheim, Bayer, and BMS/Pfizer, and consulted for Boehringer Ingelheim, Bayer, BMS/Pfizer, and Daiichi-Sankyo. Professor Lip has consulted for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Microlife, Verseon, and Daiichi-Sankyo; speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received personally. Nina Huppertz has no conflict of interest to declare.